Year: 2015-16
Company: Boehringer Ingelheim
Liaison(s): Nina Kaus Samet Serdar Yildirim
Boehringer Ingelheim (BI), is one of the world’s top 20 leading pharmaceutical companies. It was founded in 1885 by Albert Boehringer in Ingelheim, Germany, and is still headquartered there. Key product areas for BI include respiratory disease, metabolism, immunology, oncology and diseases of the central nervous system. The objectives and beliefs of BI can be summed up in a single phrase: “Value through Innovation.” BI is committed to improving the health of patients through innovation and bringing innovative products to the market. BI Biopharmaceuticals is interested in understanding how to maintain and improve innovation in the workplace. The company seeks to implement one-three changes to the internal online innovation platform that reflect the best practices in innovation management across a variety of industries. The goals of these changes are to increase usability and attractiveness of the platform. These best practices should be based upon current literature on innovation management, as well as the first hand experiences of innovation leaders. During the first semester of the project, the BI TMP team conducted a literature review and primary research interviews, to gain insight into different innovation practices for global companies. Companies interviewed varied across a variety of industries, including biopharmaceuticals, healthcare, consumer electronics, and media organizations. After a careful analysis of the results, the team designed three implementation plans – based upon the gathered data – that would enhance BI’s current innovation platform. These improvements will be carried out in coordination with BI innovation management team, with an end goal of increasing platform usage across BI’s global biopharma sites